Anixa Biosciences IncANIXEarnings & Financial Report
Nasdaq
NextApr 12, 2026
ANIX Q4 2025 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-2.9M
Net Profit
$-2.7M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.08
Anixa Biosciences Inc Q4 2025 Financial Summary
Anixa Biosciences Inc reported revenue of $0 for Q4 2025, with a net profit of $-2.7M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-2.7M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q4 2025 |
Anixa Biosciences Inc Annual Revenue by Year
Anixa Biosciences Inc annual revenue history includes year-by-year totals (for example, 2025 revenue was $0).
| Year | Annual Revenue |
|---|---|
| 2025 | $0 |
| 2024 | $0 |
| 2023 | $210.0K |
| 2022 | $513.0K |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $25.4M | $24.4M | $22.9M | $21.6M | $18.9M | $17.0M | $17.7M | $16.1M |
| Liabilities | $1.8M | $1.8M | $2.2M | $2.7M | $2.2M | $2.1M | $2.2M | $2.1M |
| Equity | $24.6M | $23.6M | $21.8M | $20.0M | $17.9M | $16.1M | $16.6M | $15.2M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-2.3M | $-1.5M | $-2.6M | $-927000 | $-2.9M | $-1.5M | $-1.5M | $-1.3M |